Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3614_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
73 Мб
Скачать
Contributorsxx
https://t.me/medicina_free
Shuichiro Takanashi , MD D e p a r t m e n t o f
Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan
Koji Takeda , MD, PhD Cardiac Surgery
Department, Columbia University, NewYork, NY, USA
Derrick Y. Tam , MD Division of Cardiac Surgery,
Department of Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada
James Tatoulis , MBBS, MS, MD, FRACS
Department of Surgery, University of Melbourne; Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, Australia
Giuseppe Tavilla , MD, PhD D e p a r t m e n t o f
Surgery, Division of Cardiac and  oracic Surgery, Scott & White Medical Center, Baylor Scott & White Health, Temple, TX, USA
Hadi Toeg , MD, MSc, MPH Division of Cardiac
Surgery, University of Ottawa Heart Institute, Ottawa, ON, Canada
Matthew I. Tomey , MD Icahn School of Medicine
at Mount Sinai, NewYork, NY, USA
Sho Torii , MD CVPath Institute, Gaithersburg,
MD, USA
Gianluca Torregrossa , MD Division of Robotic
and Minimally Invasive Cardiac Surgery, Section of Cardiac and  oracic Surgery, Department of Surgery,  e University of Chicago Medicine and Biological Sciences, Chicago, IL, USA
Nick Townsend , PhD, FHEA D e p a r t m e n t f o r
Health, University of Bath, Bath, UK
Robert F. Tranbaugh , MD D e p a r t m e n t o f
Cardiothoracic Surgery, Weill Cornell Medicine, NewYork, NY, USA
Naresh Trehan , MD Medanta  e Medicity,
Gurgaon, Haryana, India
Prashant Vaishnava , MD Mount Sinai Hospital
and Icahn School of Medicine at Mount Sinai, NewYork, NY, USA
Renu Virmani , MD CVPath Institute,
Gaithersburg, MD, USA
Alice Wang , MD Department of Surgery, Division
of Cardiovascular and  oracic Surgery, Duke University Medical Center, Durham, NC, USA
Menachem M. Weiner , MD D e p a r t m e n t o f
Anesthesiology, Perioperative, and Pain Medicine,
Icahn School of Medicine at Mount Sinai, NewYork, NY, USA
William S. Weintraub , MD, FACC C h r i s t i a n a C a r e
Health System, Newark, DE, USA
Sandra A. Weiss , MD Christiana Care Health
System, Newark, DE, USA
Mary Ann C. Wertan , RN Lankenau Medical
Center, Wynnewood, PA, USA
R. Jay Widmer , MD, PhD Division of Cardiology,
Scott & White Heart Memorial Hospital, Baylor Scott & White Health, Temple, TX, USA
Tristan D. Yan , MD, PhD, FRACS  e Collaborative
Research (CORE) Group, Macquarie University, Sydney, Australia
Bobby Yanagawa , MD, PhD, FRCSC Division of
Cardiac Surgery, St. Michael’s Hospital, University of Toronto, Toronto, O N, C ana da
Babatunde A. Yerokun , MD Department of
Surgery, Division of Cardiovascular and  oracic Surgery, Duke University Medical Center, Durham, NC, USA
Vipin Zamvar , MD Royal In rmary of Edinburgh,
Department of Cardiothoracic Surgery, Edinburgh, UK
https://t.me/medicina_free
Abbreviations
3VD three- vessel disease AAOCA anomalous aortic origin of a coronary artery AAOLCA anomalous aortic origin of the le main
coronary artery
AAORCA anomalous aortic origin of the right
coronary artery
ACAPA anomalous origin of the coronary artery from the
pulmonary artery ACC American College of Cardiology ACCF American College of Cardiology Foundation ACI Acoustic Coupling Index AHA American Heart Association AHTECAB arrested heart totally endoscopic coronary
artery bypass AI aortic insuciency ALCA anomalous le coronary artery arising from the
right sinus of Valsalva ALCAPA anomalous origin of the le coronary artery from
the pulmonary artery ARCAPA anomalous origin of the right coronary artery
from the pulmonary artery ARCAPA anomalous right coronary artery arising from the
le sinus of Valsalva ART Arterial Revascularisation Trial ARTS Arterial Revascularization erapies Study AS aortic stenosis ASA acetylsalicylic acid ASCVD atherosclerotic cardiovascular disease ASMR age- standardized mortality rate AVR aortic valve replacement AWB autologous whole blood BARI Bypass Angioplasty Revascularization
Investigation BEST Randomized Comparison of Coronary Artery
Bypass Surgery and Everolimus- Eluting Stent
Implantation in the Treatment of Patients With
Multivessel Coronary Artery Disease BF backward ow BHTECAB beating heart totally endoscopic coronary
artery bypass BITA bilateral internal thoracic artery BMI body mass index BMS bare- metal stent BP blood pressure CA contrast agent CABG coronary artery bypass gra(ing)
CAC coronary artery calcium CAD coronary artery disease cAMP cyclic adenosine monophosphate CARDia Coronary Artery Revascularization in Diabetes CBF coronary blood ow cCAB conventional coronary artery bypass graing CCS Canadian Cardiovascular Society CCTA coronary computed tomography angiogram cGMP cyclic guanosine monophosphate CI condence interval CKD chronic kidney disease CMD coronary microvascular dysfunction CMR cardiovascular magnetic resonance CO cardiac output COR class of recommendations CORONARY CABG O- or On- Pump Revascularization Study CPB cardiopulmonary bypass CSA cross- sectional area CT computed tomography CTO chronic total occlusion CTSN Cardiothoracic Surgical Clinical Trials Network CX circumex artery DAPT dual antiplatelet therapy DES drug- eluting stent DSWI deep sternal wound infection EACA epsilon- aminocaproic acid EACTS European Association for Cardio- oracic
Surgery EAS epiaortic ultrasound scanning EAUS epiaortic ultrasound ECG electrocardiogram ECMO extracorporeal membrane oxygenation ECUS epicardial ultrasound EEM external elastic membrane EF ejection fraction ERAH endoscopic radial artery harvesting ESA erythropoiesis- stimulating agent ESC European Society of Cardiology EuroSCORE European System for Cardiac Operative Risk
Evaluation EVH endoscopic vein harvesting EXCEL Evaluation of XIENCE versus Coronary Artery
Bypass Surgery for Eectiveness of Le Main
Revascularization FDA Food and Drug Administration FDG uorodeoxyglucose
Abbreviationsxxii
https://t.me/medicina_free
FFP fresh frozen plasma FFR fractional ow reserve FREEDOM Future Revascularization Evaluation in Patients
with Diabetes Mellitus:Optimal Management of
Multivessel Disease GFR glomerular ltration rate GOPCABE German O Pump Coronary Artery Bypass in
Elderly HAA hospital- acquired anaemia HCR hybrid coronary revascularization HDL high- density lipoprotein HR hazard ratio or heart rate HTK histidine– tryptophan– ketoglutarate IABP intra- aortic balloon pump ICS intercostal space ICU intensive care unit IHD ischaemic heart disease IMR ischaemic mitral regurgitation INOCA ischaemia with non- obstructive coronary artery
disease ISMICS International Society of Minimally Invasive
Cardiac Surgery ISR in- stent restenosis ITA internal thoracic artery ITT intention- to- treat IV intravenous IVUS intravascular ultrasound LAA le atrial appendage LAD le anterior descending artery LDL low- density lipoprotein LGE late gadolinium enhancement LITA le internal thoracic artery LMCA le main coronary artery LOE level of evidence LV le ventricle/ ventricular LVD le ventricular dysfunction LVEF le ventricular ejection fraction MACE major adverse cardiac events MACCE major adverse cardiac and cerebrovascular events MAG multiple arterial gra MBF myocardial blood ow MCS mechanical circulatory support MI myocardial infarction MIDCAB minimally invasive direct coronary artery graing MiECC minimal invasive extracorporeal circulation MR mitral regurgitation MRSA methicillin- resistant Staphylococcus aureus MSCT multislice computed tomography NAT no- aortic- touch NICE- SUGAR Normoglycaemia in Intensive Care Evaluation
and Survival Using Glucose Algorithm Regulation NO nitric oxide NOBLE Nordic– Baltic– British le Main Revascularization
Study NS normal saline NSTEMI non- ST- segment myocardial infraction
NT no- touch OCT optical coherence tomography OMT optimal medical therapy ONCAB on- pump coronary artery bypass graing OPCAB o- pump coronary artery bypass graing PA pulmonary artery PAC pulmonary artery catheter PBM patient blood management PCC prothrombin complex concentrate PCI percutaneous coronary intervention PCR polymerase chain reaction PDE phosphodiesterase PET positron emission tomography PI pulsatility index PREVENT Project of Ex- Vivo Vein Gra Engineering via
Transfection RA radial artery RASV right aortic sinus of Valsalva RCA right coronary artery RCT randomized controlled trial RF radiofrequency RGEA right gastroepiploic artery RIME Randomized Ischemic Mitral Evaluation RITA right internal thoracic artery ROOBY Randomized On/ O Bypass RPE rating of perceived exertion RR relative risk SCD sudden cardiac death SFA saturated fatty acid SITA single internal thoracic artery SPECT single- photon emission computed tomography SSWI supercial sternal wound infection STEMI ST- segment myocardial infraction STS Society of oracic Surgeons STS- ND Society of oracic Surgeons National Database SV saphenous vein SVG saphenous vein gra SYNTAX Synergy between Percutaneous Coronary
Intervention with Taxus and Cardiac Surgery TAR total arterial revascularization TECAB totally endoscopic coronary artery bypass TIA transient ischaemic attack TMR transmyocardial laser revascularization TOE transoesophageal echocardiography TTFM transit- time ow meter TVR target vessel revascularization TXA tranexamic acid ULMCA unprotected le main coronary artery VA CARDS Veterans Aairs Coronary Artery
Revascularization in Diabetes Study VAD ventricular assist device VAS visual analogue scale VGF vein gra failure WMSI Wall Motion Score Index
https://t.me/medicina_free
SECTION 1
Pathophysiology and investigation ofcoronary artery disease
Section editors:Thomas F.Lüscher, Valentin Fuster, and Prashant Vaishnava
1. A brief history of the surgical treatment of
coronary artery disease 3
Mario Gaudino, Stuart J.Head, and David P.Taggart
2. Epidemiology of ischaemic heart disease 9
Nick Townsend
3. Pathophysiology of coronary artery
disease 11
3.1 Regulation of coronary flow 11
Nico Bruining, Eric Boersma, and Dirk J.Duncker
3.2 Coronary endothelial function 13
R. Jay Widmer and Amir Lerman
3.3 Coronary artery spasm 16
Hiroaki Shimokawa and Jun Takahashi
3.4 The coronary microcirculation and coronary
microvascular dysfunction 18
Romana Herscovici and C.Noel Bairey Merz
3.5 Plaque rupture and erosion 21
Hiroyoshi Mori, Sho Torii, and Renu Virmani
3.6 Biology of bypass vessels and their relation
to patency and disease 23
Thomas F.Lüscher
4. Anomalous coronary arteries 31
Chin Siang Ong, Ronald K.Binder, Marshall L.Jacobs, and Duke E.Cameron
5. Non- invasive investigation of coronary
artery disease 39
5.1 Echocardiography and stress echocardiography
for coronary artery disease 39
Jae K.Oh
5.2 Nuclear cardiology 41
Aju P.Pazhenkottil and Ronny R.Buechel
5.3 Magnetic resonance imaging 45
Alexander Gotschy and Robert Manka
5.4 Cardiac computed tomography 48
Steve L.Liao
6. Ischaemia, hibernation, and viability 53
Roberto Ferrari
7. Invasive investigation of coronary artery
disease 57
7.1 Angiography 57
Matthew I.Tomey
7.2 Intravascular ultrasound 60
Lorenz Räber
7.3 Fractional flow reserve 63
Giovanni Ciccarelli, Emanuele Barbato, and Bernard De Bruyne
7.4 Optical coherence tomography 67
Keyvan Karimi Galougahi, Tomasz Roleder, Akiko Maehara, and Ziad A.Ali
https://t.me/medicina_free
https://t.me/medicina_free
1
Abrief history ofthe surgical treatment ofcoronary arterydisease
Mario Gaudino, Stuart J. Head, and David P. Taggart
Introduction
e history of the treatment of coronary artery disease (CAD) and of coronary artery bypass gra (CABG) surgery is a story of innov­ators, persistence in the face of ferocious criticism, disappointing failures, and serendipitous discovery (Fig. 1.1). It is a story of giants and visionaries.
Over almost 140years, it can be divided into four dierent eras
as follows:
Development ofscientific background and extracardiac procedures (1880– 1934)
Hammer was the rst to postulate that angina may be related to inter­ruption of blood supply to the heart in 1876. In 1880, Langer described the existence of anastomotic networks between the coronary circula­tion and surrounding structures such as the diaphragm, the lung, and the pericardium. Among the rst proposals of a surgical approach to CAD is an article from 1898 where Pratt suggested that blood ow in the coronary sinus could be reversed by the insertion of an artery. Alternatively, in 1903, orel proposed that ischaemia could be re­lieved through the formation of myopericardial adhesions. Alexis Carrel, then reported a series of animal experiments in 1910 where segments of arteries or veins were anastomosed to the aorta and the coronary arteries. In clinical practice at that time, however, the surgical treatments for CAD did not involve a direct approach to the heart.
Meanwhile, extracardiac procedures also continued to develop. In 1899, Franck recommended removal of the sympathetic thor­acic ganglia to treat angina pectoris, and in 1902, the great Swiss physician, Kocher, observed how angina disappeared aer thy­roidectomy in a patient with CAD. Jonnesco performed the rst cardiac sympathectomy in 1920, and in 1925, Mandl reported paravertebral injection of alcohol for the same purpose. Of note, the use of cardiac denervation procedures persisted for almost 40years. Boas, in 1926, performed a subtotal thyroidectomy building on the previous observations from Kocher. Finally, towards the end of this
era, Sussman described cardiac irradiation to denervate the heart and produce coronary vasodilatation in 1930.
Indirect revascularization procedures (1935– 1953)
e year 1935 marked the start of an era where cardiac surgeons dir­ectly approached the heart, but not the coronary circulation. e aim was to induce neovascularization and improve collateral circulation to the myocardium. Beck,, who was one of the pioneers of this ap­proach, described the ‘cardiopericardiopexy’ where the epicardium and visceral pericardium were mechanically abraded in the hope of inducing scar formation and neovascularization. Neovascularization was further enhanced by irritating agents such as talcum powder as well as the suturing of a pectoralis muscle ap to the heart. Alternatives tried in later years included the omentum by O’Shaugnessy in 1936, the lung by Lezius in 1937, and the jejunum by Key in 1954.
Another approach was described by Robertson and Gross who in the late 1930s partially ligated the great cardiac vein and the cor­onary sinus, respectively, with the hope that the increased venous pressure would redirect thebesian vessel blood ow into the myocar­dium. In 1939, Fieschi described ligation of the internal thoracic artery (ITA) with the aim of increasing collateral ow through the pericardiophrenic arteries back to the heart. More than 20years later, Kline and Kownacki tried to increase collateral pulmonary ow to the heart by ligating dierent parts of the pulmonary circulation.
Beck described the Beck’s Ioperation which included coronary sinus ligation, pericardial poudrage, and mediastinal fat graing.
Lillehei proposed connecting the pulmonary artery and the left atrium to increase left heart and coronary flow, and Roberts worked on an experimental model of arterialization of the coronary sinus using arterial grafts that was applied in humans by Beck in 1948. This was the Beck’s II operation which was a staged procedure of arterialization of the cor­onary sinus using saphenous vein or brachial artery implants followed by partial ligation of the coronary sinus.
1964:
2011:
disease
2018:
https://t.me/medicina_free
First
CABG
procedure
1971:
Carpentier
describes
radial artery
graft
1977:
Gruntzig:
first
balloon
angioplasty
1978:
FitzGibbon:
poor
saphenous
vein
graft
patency
at
follow-
up
1982:
CASS
trial
comparing
CABG
with medical therapy
1986:
Loop
and
Lytle:
superiority
of
LITA—
LAD to
saphenous
vein
1987:
Suma
and
Pym:
first use
of the
right
gastroepiploic
artery
for CABG
1994:
Minimally
invasive
CABG
introduced
1999:
Eduardo
Sousa:
first DES (sirolimus) implanted
2009:
SYNTAX
trial:
CABG
superior
to PCI
for
severe
coronary
artery
disease
HEART
and STICH
trials:
RCTs comparing CABG with
medical
therapy in
patients with left
ventricular
dysfunction
2013:
CORONARY:
largest
trial
comparing
on-pump
vs off­pump CABG
RADIAL:
first
RCT-
based
demonstration
of
clinical benefits with the
radial artery
1967:
Favaloro's
first
CABG
procedure
Early
1970s:
Introduction
of
cardioplegia
1977:
VA
Trial
comparing
CABG
with medical therapy
1979:
European
CABG
trial:
comparing
CABG
with
medical
therapy
1985:
Benetti
and
Buffolo
popularize
off­pump CABG
1986:
Sigwart
and
Puel:
first
implantation
of a bare
metal
stent in
human
coronary
artery
1988:
Puig-
first use
of the
inferior
epigastric
artery
as graft
1996:
Octopus stabilizer
introduced
2003:
RAPCO
trial:
first
RCT on
the radial artery
2010:
ART
trial:
first
RCT
comparing
BITA to
SITA—
operative
results
2012:
FREEDOM
trial: CABG vs PCI
in
patients
with
diabetes
2016:
EXCEL
and
NOBLE
comparing
CABG
vs
everolimus
eluting
stenting
in left
main
2018:
ART trial
at 10
years: no
difference
between
BITA and
SITA
Fig.1.1 Atimeline of the history of CABG. BITA, bilateral internal thoracic artery; CABG, coronary artery bypass graft; DES, drug- eluting stent; LAD, left anterior descending coronary artery; LITA, left
internal thoracic artery; PCI, percutaneous coronary intervention; RCT, randomized controlled trial; SITA, single internal thoracic artery.
51 Abrief history ofthe surgical treatment ofcoronary arterydisease
https://t.me/medicina_free
While myocardial acupuncture or use of needles to create channels between the ventricular cavity and the myocardium was described by Sen in 1965, the most renowned of the indirect revascularization procedures was described as tunnelling and implantation of the ITA in the myocardium in 1946 by Arthur Vineberg. Still other surgeons experimented with the use of the gastroepiploic and the intercostal arteries. In the early 1970s, aer the development of coronary angiography, the formation of a network of collaterals between the ITA and the coronary circulation was proven in some patients with severe coronary artery stenosis who underwent the Vineberg procedure. Several thousand Vineberg procedures were performed worldwide.
The modern era ofCABG (1968– present)
e rst published CABG series was reported by Johnson and Urschel between 1968 and 1970, while Spencer and Green championed the use of the ITA and of the operating microscope in NewYork City which set the stage for modern- day practice. Green performed the rst clinical le ITA– le anterior descending cor­onary artery anastomosis in the United States in February 1968.,
In 1967, Renee Favaloro reported his rst case of CABG using saphenous vein as a conduit in a patient where the planned coronary thromboendoarterectomy was found to be technically impossible. Although not the rst to describe the procedure, Favaloro’s contri­bution to CABG is unmatched, and he is usually considered the ‘fa-
Non- CABG direct revascularization procedures and first attempts atCABG (1954– 1967)
ther’ of coronary surgery (Fig. 1.2). Favaloro was the rst to perform CABG in the setting of acute myocardial infarction and among the rst to perform multivessel CABG. His lifelong collaboration with Mason Sone, who pioneered coronary angiography, underpinned the basis of modern coronary surgery.
Aer Demikhov described his experiments in canines where he graed the le ITA to the le anterior descending artery in 1952, the time had come to further explore direct revascularization. Smith
Johnson, Flemma, and Lepley were among the rst to use se­quential vein gras for CABG, while Barner introduced the use of the ITA as a free gra. In 1975, Trapp and Bisarya and Ankeney
was the rst to harvest saphenous vein for use as a gra from the aorta to the myocardium. In 1956, Bailey performed the rst closed coronary thromboendoarterectomy, and in 1958, Longmire reported the rst open procedure. Dubost performed an ostial coronary reconstruction in a patient with syphilitic aortitis in 1959. is was also the year that Mason Sone performed the rst cor­onary angiography at the Cleveland Clinic allowing a better way to evaluate coronary anatomy and pathology.
A large amount of experimental work was concurrently un­derway for the preparation of direct coronary artery anastomosis, and in 1954, Murray reported the rst successful anastomosis of a systemic artery to a coronary artery in dogs. Smith described the myocardial implantation of arterial or venous gras anastomosed to the descending aorta, and Julian performed direct CABG in dogs using cardiopulmonary bypass. In 1955, Melrose introduced the concept of cardioplegia through his experiment on stopping the heart from beating and restarting it using hyperkalaemic solutions in dogs. Finally, Goetz used an anastomotic connector for ITA– coronary anastomoses in animals. Notably, as an appendix to the article describing the dog model, he reported having performed the procedure on a patient in NewYork in May 1960 by anastomosing the right ITA to the right coronary artery. is is usually regarded as the rst clinical CABG procedure in history.
In April 1962, Sabiston performed the rst saphenous vein to coronary artery bypass procedure in a patient who had previously undergone unsuccessful thromboendoarterectomy. e patient died from a stroke on postoperative day three, and Sabiston was so dis­couraged that he abandoned the procedure for many years and did not report this landmark event until 1974.
Kolesov is credited for the rst successful hand- sewn ITA– coronary anastomosis which he performed in 1964 in Saint Petersburg (then known as Leningrad) and performed on the beating heart. Ultimately, the rst successful saphenous vein to cor­onary bypass procedure was performed in Houston later that year by Garrett, Dennis, and DeBakey, and in 1966, Favoloro success­fully performed bilateral ITA implantation using the Vineberg tech­nique at the Cleveland Clinic.
Fig.1.2 Front cover of Rene Favaloro’s Surgical Treatment of Coronary
Arteriosclerosis (1970).
SECTION 1 Pathophysiology and investigation ofcoronary artery disease6
https://t.me/medicina_free
rst demonstrated the feasibility of CABG could be performed without cardiopulmonary bypass and cardioplegia.
In 1978, FitzGibbon etal. highlighted an early failure rate of vein
procedure, the optimal techniques for performing this life- saving surgery are not yet widely agreed, underlining the need for more
carefully controlled trials. gras. In 1986, Loop and the Cleveland Clinic group established the key prognostic importance of an ITA gra to the le anterior de­scending coronary artery. Afew years later, Lytle and the same group were among the rst to systematically study the use of bilateral ITAs.
e use of the radial artery as a conduit was introduced by Carpentier in 1971, as was the gastroepiploic artery by Pym and Suma in 1987, and the inferior epigastric artery by Puig in 1990. However, early failure of the radial artery as a conduit led to its aban­donment until its revival by Cristophe Acar in 1992 with demon­stration of improved patency secondary to more rened harvesting techniques. e use of arterial conduits was further popularized with new graing methods including the T- gra introduced by Tect or in 1994.
In the 1990s, Benetti and Buolo popularized the concept of o- pump CABG. Puskas, published the rst randomized con­trolled trial of o- pump CABG among unselected patients with angiographic follow- up, demonstrating similar revascularization and patency between groups. In 1997, Rivetti and Gandra presented a series of patients describing the successful use of intracoronary shunts. Calaore etal. introduced minimally inva­sive CABG, and Duhaylongsod etal. reported a multicentre series of successful thoracoscopic harvest of the internal mammary artery in 1998. Angelini etal. were eventually the rst to describe hy­brid myocardial revascularization. In 1999, the EUROSCORE was introduced to predict early mortality in cardiac surgical patients on the basis of objective risk factors. All of this led to the conception of minimally invasive robotic surgery which was initially reported on by Falk etal. in 2000.
Since 2000, several landmark trials have been published. In 2003, the rst randomized controlled trial to assess the suitability of the ra­dial artery as a conduit, RAPCO, was initiated. In 2004, the Arterial Revascularization Trial (described extensively in Chapter34) was initiated to compare bilateral and single ITA gras, and eventually became the largest coronary artery intervention trial, whether by stents or surgery, in terms of patient numbers and length of follow­up (10years). Other published studies comparing radial artery pa­tency versus saphenous vein patency were the RAPS trial in 2004 and the RSVP trial in 2008. In 2009, the SYNTAX trial demon­strated CABG to be superior to percutaneous coronary interven­tion in terms of major adverse cardiac or cerebrovascular events in patients with severe coronary disease. e HEART and STICH trials, which compared CABG with medical therapy in patients with le ventricular dysfunction, and the FREEDOM trial, which com­pared CABG with percutaneous coronary intervention in diabetic patients, followed. In 2013, the largest trial comparing o- pump and on- pump CABG, CORONARY, demonstrated similar outcomes for o- pump and on- pump CABG, and in 2016, the results of the EXCEL trial were published.
Fiy years aer Favaloro’s rst systematic description of CABG, two landmark randomized trials (discussed in detail in subse­quent chapters) explored the current role of multiple arterial gras. RADIAL was the rst demonstration of improved clinical outcomes using multiple arterial gras and the ART trial pub­lished the 10- year outcomes of the use of single and bilateral ITA
REFERENCES
1. Westaby S. Landmarks in cardiac surgery. Oxford:Isis Medical Media; 1997, pp. 187– 92.
2. Langer L. Die Foramina thebesu in Herzen des Menschen. Sitzungsber Akad Wiss Wien. 1880;82:25– 9.
3. Pratt FH. e nutrition of the heart through the vessels of thebesius and the coronary veins. Am J Physiol. 1898;1:86– 103.
4. orel CH. Pathologie der Kreislauforgane. Ergebn allg Path path Anat. 1903;9:559.
5. Carrel A. On the experimental surgery of the thoracic aorta and heart. Am J Surg. 1910;52:83– 95.
6. Carrel A. Ultimate result of aortic transplantation. J Exp Med. 1912;15:389– 92.
7. François- Franck CA. Signication physiologique de la resection du sympathique dans la maladie de basedow, l’epilepsie, l’idiotie et le glaucome. Bull Acad Med Paris. 1899;41:565– 94.
8. Kocher A. Ueber morbus Basedowi. Mitt Grenzgeb Med Chir. 1901;1:1– 13.
9. Jonnesco T. Angine de poitrine guerie par la resection du sympathique cervicothoracique. Bull Acad Med Paris. 1920;84:93– 102.
10. Mandl F. Die Wirkung der paravertebralen Injektion bei angina pectoris. Arch Klin Chir. 1925;136:495.
11. Boas EP, Shapiro S. Further observations on patients with hypertension and increased basal metabolic rate. Am Heart J. 1926;1(5):643.
12. Sussman ML. e treatment of angina pectoris by paravertebral short wave radiation. Am J Roentgenol. 1930;24:163– 8.
13. Beck CS, Tichy VL, Moritz AR. Production of a collateral circulation to the heart. Proc Soc Exp Biol Med. 1935;32(5):759– 61.
14. Beck CS. Development of new blood supply to heart by operation. Ann Surg. 1935;102(5):801– 13.
15. O’Shaughnessy L. An experimental method of providing collateral circulation to the heart. Br J Surg. 1936;23(91):665– 70.
16. Lezius A. Die anatomischen und funktionellen Grundlagen der kiinstlichen Blutversorgung des Herzmuskels dutch die Lungen bei Coronarterien Verschluss. Arch Klin Chir. 1938;191:101.
17. Key JA, Kergin FG, Martineau Y, Leckey RG. A method of supplementing the coronary circulation by a jejunal pedicle gra. J orac Surg. 1954;28(3):320– 30.
18. Robertson HF. e reestablishment of cardiac circulation during progressive coronary occlusion. Am Heart J. 1934;10(4):533– 41.
19. Gross L, Mendlowitz M, Schauer G. Hemodynamics following experimental coronary occlusion in dogs. Exp Biol Med. 1936;35(3):446– 8.
20. Fieschi D. Criteri anatomo- siologici per intervento chirurgico lieve in malati di infarto and cuore e di angina. Arch Ital Chir. 1942;63:305– 10.
21. Kline JL, Stearn H, Bloomer WE, Leibow AA. Application of a bronchial collateral circulation to the coronary arteries by cardiopneumopexy. Am J Pathol. 1956;32(4):663– 93.
22. Kownacki RJ, Kownacki VP, Kennel AJ, Imbriglia JE, Martin WL. Collateral circulation to the heart by means of cardio­pneumonopexy and lingular vein ligation. Arch Surg. 1957;76:106.
23. Beck CS, Leighninger DS. Operations for coronary artery disease. JAMA. 1954;156(13):1226– 33.
gras. Despite the last half- century of CABG as a routine clinical
71 Abrief history ofthe surgical treatment ofcoronary arterydisease
https://t.me/medicina_free
24. Mueller RL, Rosengart TK, Isom OW. e history of surgery for ischemic heart disease. Ann orac Surg. 1997;63(3):869– 78.
25. Roberts JT, Browne RS, Roberts G. Nourishment of the myocardium by way of the coronary veins. Fed Proc. 1943;2:90.
26. Beck CS, Stanton E, Batiuchok W, Leiter E. Revascularization of the heart by gra of systemic artery into coronary sinus. JAMA. 1948;137(5):463.
27. Sen PK, Udwadia TE, Kinare SG, Parulkar GB. Transmyocardial acupuncture:a new approach to myocardial revascularization. J orac Cardiovasc Surg. 1965;50:181– 9.
28. Vineberg AM. Development of anastomosis between coronary vessels and transplanted internal mammary artery. Can Med Assoc J. 1946;55:117– 9.
29. Demikhov V. Experimental transplantation of vital organs. [Authorized translation from the Russian by Basil Haigh.] NewYork:Consultant’s Bureau; 1962.
30. Bailey CP, May A, Lemmon WM. Survival aer coronary endarterectomy in man. J Am Med Assoc. 1957;164(6):641– 6.
31. Longmire WP, Cannon JA, Kattus AA. Direct vision coronary endarterectomy for angina pectoris. N Engl J Med. 1958;259(21):993– 9.
32. Dubost C, Blondeau P, Piwnica A, Weiss M, Lenfant C, Passelecq J, etal. Syphilitic coronary obstruction. Correction under articial heart- lung and profound hypothermia at 10 degrees Celsius. Surgery. 1960;48:540– 7.
33. Sones FM Jr, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962;31:735– 8.
34. Murray G, Porcheron R, Hilario J, Roschlau W. Anastomosis of a systemic artery to the coronary. Can Med Assoc J. 1954;71(6):594– 7.
35. Smith S, Beasley M, Hodes R, Hall H, Biel E, Huth EW. Auxiliary myocardial vascularization by prosthetic gra implantation. Surg Gynecol Obstet. 1957;104(3):263– 8.
36. Melrose DG, Dreyer B, Bentall HH, Baker JBE. Elective cardiac arrest. Lancet. 1955;269(6879);21– 2.
37. Goetz RH, Rohman M, Haller JD, Dee R, Rosenak SS. Internal mammary– coronary artery anastomosis— a nonsuture method employing tantalum rings. J orac Cardiovasc Surg. 1961;41:378– 86.
38. Sabiston DC. e William F.Rienho, Jr Lecture. e coronary circulation. Bull J Hopkins Hosp. 1974;134:314– 29.
39. Kolesov VI, Potashov LV. Operations on the coronary arteries. Exp Chir Anaesth. 1965;10:3– 8.
40. Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein gra. Seven- year follow- up. JAMA. 1973;223(7):792– 4.
41. Favaloro RG. Landmarks in the development of coronary artery bypass surgery. Circulation. 1998;98(5):466– 78.
42. Spencer FC, Yong NK, Prachuabmoh K. Internal mammary­coronary artery anastomoses performed during cardiopulmonary bypass. J Cardiovasc Surg (Torino). 1964;5:292– 7.
43. Green GE, Reppert EH, Stertzer SH. Coronary arterial bypass gras. Ann orac Surg. 1968;5(5):443– 50.
44. Green GE, Paul RS, Wallsh E, Tice DA. Coronary arterial bypass graing. Surg Forum. 1968;19:159– 63.
45. Johnson WD, Flemma RJ, Lepley D Jr. Direct coronary surgery utilizing multiple- vein bypass gras. Ann orac Surg. 1970;9(5):436– 44.
46. Barner HB. e internal mammary artery as a free gra. J orac Cardiovasc Surg. 1973;66(2):219– 21.
47. Trapp WG, Bisarya R. Placement of coronary artery bypass gra without pump oxygenator. Ann orac Surg. 1975;19(1):1– 9.
48. Ankeney JL. To use or not to use pump oxygenator in coronary bypass operation. Ann orac Surg. 1975;19(1):108– 9.
49. FitzGibbon GM, Burton JR, Leach AJ. Coronary bypass gra fate: angiographic grading of 1400 consecutive gras early aer operation and of 1132 aer one year. Circulation. 1978;57(6):1070– 4.
50. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, etal. Inuence of the internal- mammary- artery gra on 10- year survival and other cardiac events. N Engl J Med. 1986;314(1):1– 6.
51. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R, etal. Two internal thoracic artery gras are better than one. J orac Cardiovasc Surg. 1999;117(5):855– 72.
52. Carpentier A, Guermonprez JL, Deloche A, Frechette C, DuBost C. e aorta- to- coronary radial artery bypass gra. Atechnique avoiding pathological changes in gras. Ann orac Surg. 1973;16(2):111– 21.
53. Pym J, Brown PM, Charrette EJ, Parker JO, West RO. Gastroepiploic- coronary anastomosis:a viable alternative bypass gra. J orac Cardiovasc Surg. 1987;94(2):256– 9.
54. Suma H, Fukumoto H, Takeuchi A. Coronary artery bypass graing by utilizing in situ right gastroepiploic artery:basic study and clinical application. Ann orac Surg. 1987;44(4):394– 7.
55. Puig LB, Ciongolli W, Cividanes GV, Dontos A, Kopel L, Bittencourt D, etal. Inferior epigastric artery as a free gra for myocardial revascularization. J orac Cardiovasc Surg. 1990;99(2):251– 5.
56. Acar C, Jebara VA, Portoghese M, Beyssen B, Pagny JY, Grare P, etal. Revival of the radial artery for coronary artery bypass graing. Ann orac Surg. 1992;54(4):652– 9; discussion 659– 60.
57. Tector AJ, Kress DC, Schmahl TM, Amundsen S. T- gra:a new method of coronary arterial revascularization. J Cardiovasc Surg (Torino). 1994;35(6):19– 23.
58. Benetti FJ, Naselli C, Wood M, Gener L. Direct myocardial re­vascularization without extracorporeal circulation. Experience in 700 patients. Chest. 1991;100(2):312– 6.
59. Buolo E, Silva de Andrade JC, Rodrigues Branco JN, Teles CA, Aguiar LF, Gomes WJ. Coronary artery bypass graing without cardiopulmonary bypass. Ann orac Surg. 1996;61(1):63– 6.
60. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, etal. O- pump vs conventional coronary artery bypass graing:early and 1- year gra patency, cost, and quality- of- life outcomes:a randomized trial. JAMA. 2004;291(15):1841– 9.
61. Puskas JD, Williams WH, Duke PG, Staples JR, Glas KE, Marshall JJ, etal. O- pump coronary artery bypass graing provides complete revascularization with reduced myocardial injury, transfusion requirements and length of stay:a prospective randomized comparison of two hundred unselected patients undergoing o- pump versus conventional coronary artery bypass graing. J orac Cardiovasc Surg. 2003;125(4):797– 808.
62. Rivetti LA, Gandra SM. Initial experience using an intraluminal shunt during revascularization of the beating heart. Ann orac Surg. 1997;63(6):1742– 7.
63. Calaore AM, Giammarco GD, Teodori G, Bosco G, D’Annunzio E, Barsotti A, etal. Le anterior descending coronary artery graing via le anterior small thoracotomy without cardiopulmonary bypass. Ann orac Surg. 1996;61(6):1658– 65.
64. Duhaylongsod F, Mayeld W, Wolf R. oracoscopic harvest of the internal thoracic artery:a multicenter experience in 218 cases. Ann orac Surg. 1998;66(3):1012– 7.
65. Angelini GD, Wilde P, Salerno TA, Bosco G, Calaore AM. Integrated le small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet. 1996;347(9003):757– 8.